Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Vemircopan in Myasthenia Gravis: NCT05218096 Clinical Landscape Report 2026
16 October 2026
NCT05218096 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Voxelotor in Anemia, Sickle Cell: NCT05228834 Clinical Landscape Report 2026
16 October 2026
NCT05228834 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Colecalciferol in Hematologic Diseases: PACTR202202814392581 Clinical Landscape Report 2026
16 October 2026
PACTR202202814392581 clinical landscape for Hematologic Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Voxelotor in Anemia, Sickle Cell: NCT05228821 Clinical Landscape Report 2026
16 October 2026
NCT05228821 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lanifibranor in Diabetes Mellitus, Type 2: NCT05232071 Clinical Landscape Report 2026
16 October 2026
NCT05232071 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Oditrasertib in Amyotrophic Lateral Sclerosis: NCT05237284 Clinical Landscape Report 2026
16 October 2026
NCT05237284 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dapagliflozin in Metabolic Dysfunction Associated Steatohepatitis: NCT05254626 Clinical Landscape Report 2026
16 October 2026
NCT05254626 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Recombinant Human Coagulation Factor VIII (Takeda) in Hemophilia A: NCT05251090 Clinical Landscape Report 2026
16 October 2026
NCT05251090 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
XENON XE 129 hyperpolarized in Idiopathic Pulmonary Fibrosis: NCT05241275 Clinical Landscape Report 2026
16 October 2026
NCT05241275 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Etavopivat in Hematologic Diseases: PACTR202202745054588 Clinical Landscape Report 2026
16 October 2026
PACTR202202745054588 clinical landscape for Hematologic Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Aspirin in Pregnancy: NCT05253781 Clinical Landscape Report 2026
16 October 2026
NCT05253781 clinical landscape for Pregnancy: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tofacitinib Citrate in Lymphoid Interstitial Pneumonia: NCT05246293 Clinical Landscape Report 2026
16 October 2026
NCT05246293 clinical landscape for Lymphoid Interstitial Pneumonia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.